Publikationen (60) Publikationen, an denen Forscher/innen teilgenommen haben

2020

  1. A Contemporary Picture of Enterococcal Endocarditis

    Journal of the American College of Cardiology, Vol. 75, Núm. 5, pp. 482-494

  2. A New Clinical and Immunovirological Score for Predicting the Risk of Late Severe Infection in Solid Organ Transplant Recipients: The CLIV Score

    The Journal of infectious diseases, Vol. 222, Núm. 3, pp. 479-487

  3. A survey to assess awareness and opinion of initiatives and recommendations on low-value diagnostic practices

    BMC Health Services Research, Vol. 20, Núm. 1

  4. Accrual of Atherosclerotic Vascular Events in a Multicenter Inception Systemic Lupus Erythematosus Cohort

    Arthritis and Rheumatology, Vol. 72, Núm. 10, pp. 1734-1740

  5. Addition of maraviroc versus placebo to standard antiretroviral therapy for initial treatment of advanced HIV infection: A randomized trial

    Annals of Internal Medicine, Vol. 172, Núm. 5, pp. 297-305

  6. Addressing low-value pharmacological prescribing in primary prevention of CVD through a structured evidence-based and theory-informed process for the design and testing of de-implementation strategies: The DE-imFAR study

    Implementation Science, Vol. 15, Núm. 1

  7. An evidence-based bundle improves the quality of care and outcomes of patients with candidaemia

    Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 3, pp. 730-737

  8. Ankle-brachial index and arterial vascular events in systemic lupus erythematosus patients: A 5-year prospective cohort

    Clinical and Experimental Rheumatology, Vol. 38, Núm. 5, pp. 978-984

  9. Avanzando para una mejor evaluación y asistencia de las personas que viven con VIH

    Revista Multidisciplinar del Sida, Vol. 8, Núm. 21, pp. 3-6

  10. Brief Report: CYP27B1 rs10877012 T Allele Was Linked to Non-AIDS Progression in ART-Naïve HIV-Infected Patients: A Retrospective Study

    Journal of acquired immune deficiency syndromes (1999), Vol. 85, Núm. 5, pp. 659-664

  11. Burnout syndrome in internal medicine specialists and factors associated with its onset

    Revista Clinica Espanola, Vol. 220, Núm. 6, pp. 331-338

  12. COVID-19: Faciam ut potero

    Gaceta Medica de Bilbao

  13. Can we effectively treat lupus and reduce the side-effects of glucocorticoids?

    The Lancet Rheumatology

  14. Catheter-related bloodstream infections: predictive factors for Gram-negative bacteria aetiology and 30 day mortality in a multicentre prospective cohort

    The Journal of antimicrobial chemotherapy, Vol. 75, Núm. 10, pp. 3056-3061

  15. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

    Clinical Microbiology and Infection, Vol. 26, Núm. 11, pp. 1525-1536

  16. Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry

    Lupus, Vol. 29, Núm. 11, pp. 1353-1363

  17. Comparative study between two european inception cohorts of patients with early systemic lupus erythematosus

    Clinical and Experimental Rheumatology, Vol. 38, Núm. 5, pp. 925-932

  18. Construction of a frailty index as a novel health measure in systemic lupus erythematosus

    Journal of Rheumatology, Vol. 47, Núm. 1, pp. 72-81

  19. Coronavirus disease 2019 in patients with HIV in the province of Araba, Basque Country, Spain

    AIDS (London, England)

  20. Cytomegalovirus antibody levels and mortality among hospitalised elderly patients

    Annals of Medicine, Vol. 52, Núm. 8, pp. 497-505